Repligen | RGEN - Ativo Circulante





Ativo Circulante Alterar Data
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 38.87M 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Bruker USD 2.1B 108.9M 2026-03
Charles River Laboratories USD 1.49B 41.76M 2026-03
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.85B 178M 2026-03
General Electric Aerospace USD 39.7B 664M 2026-06
Henry Schein USD 4.5B 32M 2026-03
Illumina USD 2.74B 551M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Mettler Toledo International USD 1.33B 30.76M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
OraSure Technologies USD 240.78M 21.13M 2026-03
Pacific Biosciences Of California USD 369.52M 5.54M 2026-03
Pfizer USD 42.82B 76M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Waters USD 3.72B 1.73B 2026-03
West Pharmaceutical Services USD 1.81B 19.3M 2026-06